# Nextech V Oncology S.C.S., SICAV-SIF — Form D

Nextech V Oncology S.C.S., SICAV-SIF of LUXEMBOURG-FINDEL, N4, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-09-20. The offering totals $350.0M, of which $46.7M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2017-09-20
- Form: D
- Accession: 0001712922-17-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Total offering: $350.0M
- Amount sold: $46.7M
- Remaining: $303.3M
- Minimum investment: $1.0M
- Investors: 5
- Date of first sale: 2017-09-12
- Security types: fund interests
- SEC file number: 021-295084

## Issuer

- Name: Nextech V Oncology S.C.S., SICAV-SIF
- CIK: 0001712922
- Entity type: Limited Partnership
- Jurisdiction: LUXEMBOURG
- Incorporated: 2017
- Address: 7, RUE LOU HEMMER, LUXEMBOURG-FINDEL, N4, L-1748
- Phone: 352-246-160-6000

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| THOMAS LIPS | Executive Officer | ZURICH, V8 |
| N/A NEXTECH V GP S.a.r.l. | Executive Officer | LUXEMBOURG-FINDEL, N4 |
| James Pledger | Executive Officer | Luxembourg, N4 |
| James Vella-Bamber | Executive Officer | Senningerberg, N4 |
| N/A NEXTECH INVEST AG | Promoter | LUXEMBOURG-FINDEL, N4 |

## More

- [CIK 1712922 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1712922&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001712922-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.